BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 24951766)

  • 1. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
    Ryan JJ; Archer SL
    Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension.
    Piao L; Fang YH; Parikh K; Ryan JJ; Toth PT; Archer SL
    J Mol Med (Berl); 2013 Oct; 91(10):1185-97. PubMed ID: 23794090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRK2-mediated inhibition of adrenergic and dopaminergic signaling in right ventricular hypertrophy: therapeutic implications in pulmonary hypertension.
    Piao L; Fang YH; Parikh KS; Ryan JJ; D'Souza KM; Theccanat T; Toth PT; Pogoriler J; Paul J; Blaxall BC; Akhter SA; Archer SL
    Circulation; 2012 Dec; 126(24):2859-69. PubMed ID: 23124027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure.
    Piao L; Marsboom G; Archer SL
    J Mol Med (Berl); 2010 Oct; 88(10):1011-20. PubMed ID: 20820751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension.
    Sutendra G; Dromparis P; Paulin R; Zervopoulos S; Haromy A; Nagendran J; Michelakis ED
    J Mol Med (Berl); 2013 Nov; 91(11):1315-27. PubMed ID: 23846254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Right ventricular cyclic nucleotide signaling is decreased in hyperoxia-induced pulmonary hypertension in neonatal mice.
    Heilman RP; Lagoski MB; Lee KJ; Taylor JM; Kim GA; Berkelhamer SK; Steinhorn RH; Farrow KN
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1575-82. PubMed ID: 25862831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
    Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
    Fang YH; Piao L; Hong Z; Toth PT; Marsboom G; Bache-Wiig P; Rehman J; Archer SL
    J Mol Med (Berl); 2012 Jan; 90(1):31-43. PubMed ID: 21874543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
    Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
    Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
    Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and bioenergetics in the right ventricle and pulmonary vasculature in pulmonary hypertension.
    Archer SL; Fang YH; Ryan JJ; Piao L
    Pulm Circ; 2013 Jan; 3(1):144-52. PubMed ID: 23662191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
    Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular adaptation and failure in pulmonary arterial hypertension.
    Ryan JJ; Huston J; Kutty S; Hatton ND; Bowman L; Tian L; Herr JE; Johri AM; Archer SL
    Can J Cardiol; 2015 Apr; 31(4):391-406. PubMed ID: 25840092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
    Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
    Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right Ventricular Fibrosis.
    Andersen S; Nielsen-Kudsk JE; Vonk Noordegraaf A; de Man FS
    Circulation; 2019 Jan; 139(2):269-285. PubMed ID: 30615500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FHL-1 is not involved in pressure overload-induced maladaptive right ventricular remodeling and dysfunction.
    Veith C; Neghabian D; Luitel H; Wilhelm J; Egemnazarov B; Muntanjohl C; Fischer JH; Dahal BK; Schermuly RT; Ghofrani HA; Grimminger F; Fink L; Kwapiszewska G; Weissmann N; Sydykov A
    Basic Res Cardiol; 2020 Jan; 115(2):17. PubMed ID: 31980934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of capillary density-stroke work mismatch for right ventricular adaptation to chronic pressure overload.
    Noly PE; Haddad F; Arthur-Ataam J; Langer N; Dorfmüller P; Loisel F; Guihaire J; Decante B; Lamrani L; Fadel E; Mercier O
    J Thorac Cardiovasc Surg; 2017 Dec; 154(6):2070-2079. PubMed ID: 28712579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cGMP in the physiological and molecular responses of the right ventricle to pressure overload.
    Janssen W; Schermuly RT; Kojonazarov B
    Exp Physiol; 2013 Aug; 98(8):1274-8. PubMed ID: 23873899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the microRNA signature driving adaptive right ventricular hypertrophy in an ovine model of congenital heart disease.
    Kameny RJ; He Y; Zhu T; Gong W; Raff GW; Chapin CJ; Datar SA; Boehme JT; Hata A; Fineman JR
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H847-H854. PubMed ID: 29906222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure.
    Rajagopalan V; Zhao M; Reddy S; Fajardo G; Wang X; Dewey S; Gomes AV; Bernstein D
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H551-62. PubMed ID: 23729213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.